Baxter announced that Gammagard Liquid (immune globulin infusion [human]) has been approved for subcutaneous administration, which allows patients to self-administer the therapy at home. Gammagard Liquid is already indicated for IV administration as replacement therapy for primary humoral immunodeficiency in adult and pediatric patients ≥2years of age.

For more information call (866) 424-6724 or visit